Experimental models of hepatic encephalopathy: ISHEN guidelines.
about
Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosisCurrent pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathyImpaired novelty acquisition and synaptic plasticity in congenital hyperammonemia caused by hepatic glutamine synthetase deficiencyHyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shuntsTHDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapyAmmonia toxicity to the brain.Brain magnetic resonance in experimental acute-on-chronic liver failure.Cerebral oedema is not responsible for motor or cognitive deficits in rats with hepatic encephalopathy.Murine model to study brain, behavior and immunity during hepatic encephalopathyAmmonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.Noncirrhotic Portal Vein Thrombosis Presenting with Hepatic Encephalopathy Due to Polycythemia Vera and MRI Findings.Retinoids modulate thioacetamide-induced acute hepatotoxicityImpairment of the organization of locomotor and exploratory behaviors in bile duct-ligated ratsAcute liver failure in rats activates glutamine-glutamate cycle but declines antioxidant enzymes to induce oxidative stress in cerebral cortex and cerebellumThioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes.Low-light-level therapy as a treatment for minimal hepatic encephalopathy: behavioural and brain assessment.A morphological method for ammonia detection in liverAmmonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy.Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated ratsNitrosative Stress-Induced Disruption of Baroreflex Neural Circuits in a Rat Model of Hepatic Encephalopathy: A DTI Study.Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy.Effects of cholestasis on learning and locomotor activity in bile duct ligated rats.Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?Hepatic encephalopathy: effects of liver failure on brain function.Concurrent assessment of calpain and caspase3 activities in brains of mice with acetaminophen-induced acute hepatic encephalopathy.Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.Ammonia toxicity: from head to toe?Reducing Peripheral Inflammation with Infliximab Reduces Neuroinflammation and Improves Cognition in Rats with Hepatic Encephalopathy.Mapping metabolic brain activity in three models of hepatic encephalopathy.Gut microbiota drive the development of neuroinflammatory response in cirrhosis in miceNeuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.Ammonia-induced brain swelling and neurotoxicity in an organotypic slice model.(1)H and (31)P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism.Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy.Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota CompositionEffect of taurine on chronic and acute liver injury: Focus on blood and brain ammoniaHepatic encephalopathy: An approach to its multiple pathophysiological features.Pregnenolone sulfate restores the glutamate-nitric-oxide-cGMP pathway and extracellular GABA in cerebellum and learning and motor coordination in hyperammonemic rats.
P2860
Q26778000-8380148B-3FE2-42A0-BE00-3612AC98E368Q27003171-3C08E4D0-4BE1-493D-B2B9-3C0EA11E1EF6Q28397860-CF61C65C-A188-497C-A977-F0D2F7E36236Q28538254-784D9F18-1552-4857-BB3E-0E00ABE7689EQ28543895-B6E08497-2FD9-4F07-9E4E-8D44A7C07FF5Q30575263-5ED82FEB-FF8F-4301-AD1C-4E963186B20AQ30584892-B9F627AC-3F57-45A3-AA40-CD627EF4165EQ30656195-BFB00314-7344-4B5D-8921-D81AE50D4BA8Q33563902-E387918F-8EEF-4193-B5B9-AA5FDF35474FQ33578206-9ABBB1FF-9929-408C-99AB-EBC01A705819Q33711140-C6FDA723-D8C9-4B05-A819-838197928890Q33779952-B0D107D6-A0FD-4700-B951-89634ADEA982Q34269099-BBE9DF54-B585-43F4-ADB3-D61C8800152DQ35155005-BEEDFF4E-EFF9-4DCE-BDF5-4AFC28003D83Q36022644-73FFD875-736C-4943-A1AB-2B6C580AF7FDQ36094395-6CDE37CB-C3D0-4141-86E5-5FA47ECC165AQ36314745-C87D5101-F22A-4898-9442-46F16C78EB56Q36569505-4BF691D1-7C8A-4AF5-842D-2541DFDE8AD7Q36670749-9AA343E8-A0A1-4564-829E-F2CE96735C99Q37151581-C0634096-8266-4892-A11E-5C58494F6A00Q37581557-58F9BFBD-0890-4D05-A178-DC8EA22653C1Q37627757-A070FB4C-B2B3-4D2C-A53D-FC789373BC2EQ37633380-43AA3730-FEB9-445F-98F4-C7B6C70979C6Q37634697-92407071-74C5-4F43-9C2E-6F10F85F0106Q37710176-446767D4-2AA6-4DF7-8180-0F9B2CDD15A0Q38154754-37F31146-C9E1-4148-A845-802D632E4E23Q38638929-47F4FF47-1A7A-4AEC-85AE-E4A4CF74B71CQ38861352-59AE4C7A-8C13-427B-9960-0C0F5CA7771EQ39052232-21743007-4E00-4FF5-96C3-796F6FE2CA94Q39182053-7C01E016-E895-4CBC-BFD6-BB7179BF6F31Q39447593-87DA3A10-FF56-41CD-B29B-5309C7DC6FD1Q39658427-D199A160-AA7F-4C37-85F5-5A2DDE2A4B8FQ40321458-F397016A-157D-4C4D-A258-0508194AC896Q40589602-9986EA05-4C84-4223-AD68-818C69788A45Q40647592-E6F7220E-C17B-4C37-A931-8E65308ABFACQ41085679-063DA353-35D1-4117-8276-4BF161879FACQ41246828-C870A967-8B4B-4E82-89BC-E22314172E42Q41679488-C4E2FC7C-5616-45EC-AF69-6A6904851F97Q41813389-ECDCD117-C58A-49DE-A8D8-2D48B560A9E6Q41969929-1F06A91C-D7D5-4FC7-8BEA-26101AAD2F6F
P2860
Experimental models of hepatic encephalopathy: ISHEN guidelines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimental models of hepatic encephalopathy: ISHEN guidelines.
@en
Experimental models of hepatic encephalopathy: ISHEN guidelines.
@nl
type
label
Experimental models of hepatic encephalopathy: ISHEN guidelines.
@en
Experimental models of hepatic encephalopathy: ISHEN guidelines.
@nl
prefLabel
Experimental models of hepatic encephalopathy: ISHEN guidelines.
@en
Experimental models of hepatic encephalopathy: ISHEN guidelines.
@nl
P2093
P1433
P1476
Experimental models of hepatic encephalopathy: ISHEN guidelines
@en
P2093
Andres T Blei
Members of the ISHEN Commission on Experimental Models of HE
Michael D Norenberg
Peter Ferenci
Roger F Butterworth
P304
P356
10.1111/J.1478-3231.2009.02034.X
P577
2009-07-01T00:00:00Z